-
Oncogenic Ectodomain deletion of FGFR1 caused by Breakage-Fusion-Bridges in Squamous Cell lung Cancer
Study
EGAS00001005059
-
Mutant p53 confers gain-of-function transcriptional activity in liver cancer
Study
EGAS00001005779
-
Unraveling the genetics of transformed splenic marginal zone lymphoma
Study
EGAS00001006389
-
Leukemia sequencing study
Study
EGAS00001006901
-
Detection of rare mutations, copy number variation, and DNA methylation in the same template DNA molecules
Study
EGAS00001006839
-
Targeted sequence of MDS cases treated with azacitidine
Study
EGAS00001007030
-
Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer
Study
EGAS00001003233
-
SCANDARE MACARON
Study
EGAS50000000145
-
The INFORM Precision Medicine Study for High-Risk Pediatric Malignancies
Study
EGAS00001005112
-
Correlative Genomic Analysis of Durvalumab plus Pazopanib Combination in Patients with Advanced Soft Tissue Sarcomas
Study
EGAS50000000082
-
Sequencing of Ovarian Cancer
Study
EGAS00001007489
-
Sequencing of Breast Cancer
Study
EGAS00001007490
-
Converging and evolving immuno-genomic routes towards immune escape in breast cancer
Study
EGAS00001004956
-
Multimodal epigenetic sequencing analysis for colon cancer
Study
EGAS50000000052
-
MediMer: A versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection
Study
EGAS50000000065
-
AVENIO Expanded ctDNA panel sequence alignments (BAMs) from plasma DNA of lung cancer patients from the OSCILLATE trial
Study
EGAS50000000103
-
Immunomodulatory effects and improved outcomes with cisplatin- vs carboplatin-based chemotherapy plus atezolizumab in urothelial cancer
Study
EGAS50000000104
-
Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway
Study
EGAS50000000136
-
Evolutionary Trajectories of Small Cell Lung Cancer under Therapy
Study
EGAS50000000169
-
Oxel Pilot Study
Study
EGAS50000000222
-
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer
Study
EGAS50000000211
-
Lung cancer cfDNA dataset DAC
Dac
EGAC00001002994
-
Ovarian cancer cfDNA dataset DAC
Dac
EGAC00001003234
-
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer
Dataset
EGAD50000000303
-
Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer
Study
EGAS50000000212